Edwards Lifesciences has a total of 1532 patents globally, out of which 879 have been granted. Of these 1532 patents, more than 62% patents are active. United States Of America is where Edwards Lifesciences has filed the maximum number of patents, followed by Europe and Germany. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Edwards Lifesciences.
Edwards Lifesciences was founded in 1958 by Lowell Edwards. Edwards Lifesciences designs, develops, and markets products and services for the treatment of cardiovascular diseases. The Company provides transcatheter heart and surgical heart valves, heat valve repair, cardiac cannula, hemodynamic monitoring, pressure monitoring, vascular surgery, and investigational devices. Edwards Lifesciences serves customers worldwide. As of April 2022 Edwards Lifesciences has a market cap of $75.48 Billion.
Do read about some of the most popular patents of Edwards Lifesciences which have been covered by us in this article and also you can find Edwards Lifesciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Edwards Lifesciences patent portfolio.
How many patents does the Founder and CEO of Edwards Lifesciences have?
The Founder & CEO, Lowell Edwards and Michael A Mussallem has 61 and 0 patents respectively.
How many patents does Edwards Lifesciences have?
Edwards Lifesciences has a total of 1532 patents globally. These patents belong to 316 unique patent families. Out of 1532 patents, 958 patents are active.
How Many Patents did Edwards Lifesciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Edwards Lifesciences Applications Filed | Edwards Lifesciences Patents Granted |
| 2010 | 77 | 27 |
| 2011 | 57 | 26 |
| 2012 | 55 | 31 |
| 2013 | 70 | 44 |
| 2014 | 120 | 39 |
| 2015 | 71 | 45 |
| 2016 | 98 | 66 |
| 2017 | 46 | 68 |
| 2018 | 82 | 75 |
| 2019 | 63 | 84 |
| 2020 | 69 | 105 |
| 2021 | 55 | 87 |
| 2022 | – | 23 |
How many Edwards Lifesciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Edwards Lifesciences File in Different Countries?
Countries in which Edwards Lifesciences Filed Patents
| Country | Patents |
| United States Of America | 588 |
| Europe | 209 |
| Germany | 120 |
| Canada | 99 |
| China | 72 |
| Australia | 67 |
| Japan | 62 |
| Singapore | 25 |
| Spain | 24 |
| Israel | 23 |
| Hong Kong (S.A.R.) | 21 |
| Austria | 21 |
| Costa Rica | 14 |
| India | 10 |
| United Kingdom | 9 |
| Korea (South) | 9 |
| Brazil | 8 |
| Mexico | 6 |
| Denmark | 5 |
| Portugal | 5 |
| South Africa | 3 |
| Lithuania | 2 |
| Slovenia | 2 |
| Poland | 2 |
| Sweden | 2 |
| Croatia | 1 |
| New Zealand | 1 |
| Hungary | 1 |
| Serbia | 1 |
| Turkey | 1 |
Where are Research Centers of Edwards Lifesciences Patents Located?
10 Best Edwards Lifesciences Patents
US6730118B2 is the most popular patent in the Edwards Lifesciences portfolio. It has received 2140 citations so far from companies like Cook Inc and Micardia Corporation.
Below is the list of 10 most cited patents of Edwards Lifesciences:
| Publication Number | Citation Count |
| US6730118B2 | 2140 |
| US6893460B2 | 1477 |
| US6908481B2 | 1404 |
| US6582462B1 | 1027 |
| US8523881B2 | 1000 |
| US6723038B1 | 953 |
| US7510575B2 | 935 |
| US7585321B2 | 915 |
| US6764510B2 | 893 |
| US6406420B1 | 886 |
Which Companies are using Edwards Lifesciences Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Edwards Lifesciences patent portfolio are Boston Scientific, Medtronic and St Jude Medical Cardiology Division.
List of the top forward citing Companies –
| Company | Number Of Patents |
| Boston Scientific | 50 |
| Medtronic | 42 |
| St Jude Medical Cardiology Division | 40 |
| Medtronic Vascular | 17 |
| Bioventrix | 14 |
| Tendyne Holdings | 13 |
| Twelve | 10 |
| Colibri Heart Valve | 10 |
| Volcano | 10 |
| St Jude Medical | 9 |
Count of 102 and 103 Type Rejections based on Edwards Lifesciences Patents
Top Edwards Lifesciences Patents used in Rejecting Most Patent Applications
| Patent Number | Count of Rejected Applications |
| US6730118B2 | 32 |
| US7510572B2 | 30 |
| US8182530B2 | 27 |
| US7510575B2 | 22 |
| US8403983B2 | 21 |
| US6908481B2 | 21 |
| US8579964B2 | 21 |
| US7803185B2 | 18 |
| US20060241745A1 | 17 |
| US8414644B2 | 17 |
What Percentage of Edwards Lifesciences US Patent Applications were Granted?
Edwards Lifesciences (Excluding its subsidiaries) has filed 306 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 242 have been granted leading to a grant rate of 82.03%.
Below are the key stats of Edwards Lifesciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Edwards Lifesciences?
| Law Firm | Total Applications | Success Rate |
| Bozicevic Field & Francis | 26 | 69.23% |
| Finnegan Henderson Farabow Garrett & Dunner | 14 | 0.00% |
| Hartman Global | 9 | 100.00% |
| Adsero | 6 | 100.00% |
| Edwards Lifesciences Llc | 4 | 100.00% |
| Novadaq Technologies Inc | 4 | 25.00% |
| Polsinelli | 4 | 0% |
| Joseph F Shirtz | 3 | 33.33% |
| Stryker European Operations | 3 | 100.00% |
| Bd Rutan & Tucker | 2 | 50.00% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Synopsys’ key innovation segments?